I read the whole post and it is not really clear what argument you are making. At least not to me.
You complained about the FDA not having approved A2's application yet. Then someone asked you what expect A2 to do about that. Then you gave a long list of things unrelated to this. Now I take it you are implying that A2 should not have put it in to begin with, because entering the USA is an unreasonable use of capital and resources?
I am not cherry picking, I am genuinely trying to work out what you mean. Can you just say what your point is?
A2M Price at posting:
$4.63 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)